-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster II

Symposia: Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Aya Shibuya, PhD1, Lucy Liu, MD, PhD1*, Mark C Wilkes, PhD1, Nan Wang, PhD1*, Leonardo Daniels1*, Jayla Taylor1*, Bertil Glader, MD, PhD2 and Kathleen M. Sakamoto, MD, PhD3

1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
2Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
3Department of Pediatrics, Stanford University, Stanford, CA

Nozomu Kawashima, MD1*, Usua Oyarbide, PhD2 and Seth J Corey, MD2

1Lerner Research Institute/Department of Cancer Biology, Cleveland Clinic, Cleveland, OH
2Departments of Pediatrics and Cancer Biology, Cleveland Clinic, Cleveland, OH

Michael Poeschla, BA1*, Uma Arora, PhD2*, Lisa J. McReynolds, MD, PhD3, Mitchell Machiela4*, Sharon A Savage, MD5 and Vijay G. Sankaran6

1Harvard Medical School, Brookline, MA
2Boston Children's Hospital, Boston
3Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, NIH, Bethesda, MD
4National Cancer Institute, Bethesda, MA
5Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD
6Boston Children's Hospital, Boston, MA

Sarada Ketharnathan, PhD1, Sujata Pokharel, BSc1*, Kevin Ban, BSc1*, Sergey V Prykhozhij, PhD1*, Anna Cordeiro, PhD2*, Elaine W. Leung, MD, FRCPC3, Mira Liebman, MD3*, Miroslava Cuperlovic-Culf4*, Yigal Dror, MD, FRCPC5 and Jason Berman, MD1

1CHEO Research Institute, Ottawa, ON, Canada
2AGADA Biosciences, Halifax, NS, Canada
3Children's Hospital of Eastern Ontario, Ottawa, ON, CAN
4Digital Technologies Research Centre, National Research Council of Canada, Ottawa, ON, CAN
5Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada

Senthil V. Bhoopalan, MBBS, PhD1*, Ruopeng Feng, PhD2, Thiyagaraj Mayuranathan2*, Kalin Mayberry2*, Yoonjeong Jang, DVM, PhD2, Jonathan S Yen, PhD3, Yu Yao, MD4*, Lance Palmer, PhD2*, Yong Cheng, PhD5, Marcin W. Wlodarski, MD, PhD2 and Mitchell Weiss, MD, PhD4

1St Jude Children's Research Hospital, Memphis, TN
2St. Jude Children's Research Hospital, Memphis, TN
3Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
4Dept. of Hematology, St. Jude Children's Research Hospital, Memphis, TN
5St. Jude Children's Rsesearch Hospital, Memphis, TN

Ji Zha, PhD, BS1, Rheanna Grace Congdon, BS1*, Lori Kunselman1*, Olivia Bigham, BS1* and Timothy S Olson, MD, PhD1,2

1Cell Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Ondrej Jahoda1*, Dana Dobesova2*, Katarina Hlusickova Kapralova1*, Simona Kurekova1*, Dagmar Pospisilova3*, Vladimir Divoky1,4, David Friedecky2* and Monika Horvathova, MSc4,5

1Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
2Department of Clinical Biochemistry, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
3Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
4Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
5Department of Biology, Faculty of Medicine, Palacky University, Olomouc, Czech Republic

Fernanda Gutierrez-Rodrigues, PhD1, Natthakan Thongon, PhD2, Christopher L Williams, BS, MSc3*, Simona Colla, PhD4, Neal S. Young, MD5 and Alison A. Bertuch, MD, PhD3

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, Bethesda, MD
2Leukemia, MD Anderson Cancer Center, Houston, TX
3Baylor College of Medicine, Department of Pediatrics, Houston, TX
4MD Anderson Cancer Center, HOUSTON, TX
5Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Christopher Haddad1*, Yasuo Kubota, MD, PhD2*, Carlos Bravo-Perez, MD, PhD2,3*, Carmelo Gurnari, MD2,4, Luca Guarnera, MD2,4*, Olisaemeka Ogbue2, Arda Durmaz, PhD2*, Ishani Nautiyal, BS2*, Aashray Mandala, BS2*, David S. Bosler, MD5*, Hetty E. Carraway, MD, MBA6, Yogen Saunthararajah, MD2, Valeria Visconte, PhD2 and Jaroslaw P. Maciejewski, M.D., Ph.D., FACP2

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Westlake, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
4Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
5Pathology and Laboratory Medicine Institute (Robert J. Tomsich), Cleveland, OH
6Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH

Sarada Ketharnathan, PhD1, Sujata Pokharel, BSc1*, Sergey V Prykhozhij, PhD1*, Anna Cordeiro, PhD2*, Elaine W. Leung, MD, FRCPC3, William Mannherz, BS4, Yigal Dror, MD, FRCPC5, Suneet Agarwal, MD, PhD6 and Jason Berman, MD1

1CHEO Research Institute, Ottawa, ON, Canada
2AGADA Biosciences, Halifax, NS, Canada
3Children's Hospital of Eastern Ontario, Ottawa, ON, CAN
4Boston Children's Hospital, Boston, MA
5Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada
6Children's Hospital Boston, Boston, MA

Mayu Morishita, PhD1*, Miharu Yabe2*, Nobuyuki Kakiuchi, MD, PhD3,4,5*, Minoru Takata, MD, PhD6*, Kotoe Katayama7*, Seiya Imoto8*, Seishi Ogawa3,9,10, Hiromasa Yabe2* and Kenichi Yoshida, MD, PhD1

1Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan
2Department of Pediatrics, Tokai University, Isehara, Japan
3Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
4The Hakubi Center for Advanced Research, Kyoto University, Kyoto, Japan
5Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan
6Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Kyoto University, Kyoto, Japan
7Laboratory of Sequence Analysis, Human Genome Center, The University of Tokyo, Tokyo, Japan
8Division of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
9Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
10Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden

*signifies non-member of ASH